Cargando…
Extracellular lipidome change by an SGLT2 inhibitor, luseogliflozin, contributes to prevent skeletal muscle atrophy in db/db mice
BACKGROUND: Diabetes mellitus increases the excretion of urinary glucose from the renal glomeruli due to elevated blood glucose levels. In the renal tubules, SGLT2 is expressed and reabsorbs the excreted urinary glucose. In the pathogenesis of diabetes mellitus, glucose reabsorption by SGLT2 is incr...
Autores principales: | Bamba, Ryo, Okamura, Takuro, Hashimoto, Yoshitaka, Majima, Saori, Senmaru, Takafumi, Ushigome, Emi, Nakanishi, Naoko, Asano, Mai, Yamazaki, Masahiro, Takakuwa, Hiroshi, Hamaguchi, Masahide, Fukui, Michiaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818690/ https://www.ncbi.nlm.nih.gov/pubmed/34854254 http://dx.doi.org/10.1002/jcsm.12814 |
Ejemplares similares
-
Gut Microbiota Changes by an SGLT2 Inhibitor, Luseogliflozin, Alters Metabolites Compared with Those in a Low Carbohydrate Diet in db/db Mice
por: Hata, Shinnosuke, et al.
Publicado: (2022) -
Milk protects against sarcopenic obesity due to increase in the genus Akkermansia in faeces of db/db mice
por: Okamura, Takuro, et al.
Publicado: (2023) -
Effects of Royal Jelly on Gut Dysbiosis and NAFLD in db/db Mice
por: Kobayashi, Genki, et al.
Publicado: (2023) -
The sodium-glucose cotransporter 2 inhibitor luseogliflozin can suppress muscle atrophy in Db/Db mice by suppressing the expression of foxo1
por: Okamura, Takuro, et al.
Publicado: (2019) -
Trans Fatty Acid Intake Induces Intestinal Inflammation and Impaired Glucose Tolerance
por: Okamura, Takuro, et al.
Publicado: (2021)